-
If you purchased shares of Chyronhego Corp (NASDAQ:CHYR) and currently hold any of those NASDAQ:CHYR shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
December 1, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Chyronhego Corp (NASDAQ:CHYR), was announced concerning whether the takeover of Chyronhego Corp. by Vector Capital for $2.82 per share is unfair to NASDAQ:CHYR stockholders.
The investigation by a law firm concerns whether certain officers and directors of Chyronhego Corp breached their fiduciary duties owed to NASDAQ:CHYR investors in connection with the proposed acquisition.
On November 17, 2014, Chyronhego Corp (NASDAQ:CHYR) announced that it has entered into a merger agreement with affiliates of Vector Capital under which an affiliate of Vector Capital will acquire all of the outstanding shares of Chyronhego Corp (NASDAQ:CHYR) common stock for $2.82 per share in cash.
.
However, given that at least one analyst has set the high target for NASDAQ:CHYR shares at $4.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:CHYR stockholders.
In addition, given that in connection with the execution of the porposed transaction, Mr. Johan Apel, ChyronHego President & CEO, the directors and executive officers of the Company and certain significant stockholders of the Company, who currently own approximately 51% of the Company's outstanding shares, have already agreed to vote their shares in favor of the merger, the investigation concerns whether the Chyronhego Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Chyronhego Corp reported that its annual Total Revenue rose from $30.22 million in 2012 to $47.41 million in 2013 and that its respective Net loss declined from $22.30 million to $7.84 million.
Shares of Chyronhego Corp (NASDAQ:CHYR) grew from $0.58 per share in November 2012 to as high as $3.09 per share in January 2014, respectively $3.20 per share in September 2014.
